Extended Data Fig. 5: Example of ADNKA gating strategy. | Nature Medicine

Extended Data Fig. 5: Example of ADNKA gating strategy.

From: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Extended Data Fig. 5

Viable NK-92® expressing human CD16 were identified by FSC-A vs SSC-A gating, followed by GFP expression, and Live/Dead stain. CD107a expression was then determined from this gated population, an unstimulated sample is shown in the top right panel, and stimulation with a convalescent sample is shown on the bottom right panel.

Back to article page